Dean J. Naisbitt

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Gary Middleton, Paul Silcocks, Trevor F. Cox et al. · The Lancet Oncology · 2014 · 370 citations · Full text

Pancreatic Cancer, Medicine, Immunology +5

Human Leukocyte Antigen (HLA)-B*57:01-Restricted Activation of Drug-Specific T cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury

Manal Monshi, Lee Faulkner, Andrew Gibson et al. · Hepatology · 2012 · 249 citations · Full text

Hypersensitivity Reactions to Carbamazepine: Characterization of the Specificity, Phenotype, and Cytokine Profile of Drug-Specific T Cell Clones

Dean J. Naisbitt, Markus Britschgi, G. A. E. Wong et al. · Molecular Pharmacology · 2003 · 218 citations

Recognition of Sulfamethoxazole and Its Reactive Metabolites by Drug-Specific CD4+ T Cells from Allergic Individuals

Benno Schnyder, Christoph Burkhart, Karin Schnyder-Frutig et al. · The Journal of Immunology · 2000 · 212 citations · Full text

Characterization of drug-specific T cells in lamotrigine hypersensitivity

Dean J. Naisbitt, John Farrell, Gavin Wong et al. · Journal of Allergy and Clinical Immunology · 2003 · 207 citations · Full text

Allergy, Medicine, Immunology +5